116 related articles for article (PubMed ID: 21204770)
1. A case of rituximab-induced hepatitis.
Del Prete CJ; Cohen NS
Cancer Biother Radiopharm; 2010 Dec; 25(6):747-8. PubMed ID: 21204770
[TBL] [Abstract][Full Text] [Related]
2. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
Toubi E
Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
[TBL] [Abstract][Full Text] [Related]
3. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
Gray C; Kalumba K; Pati N; Peterson A; Connell TG
J Pediatr Hematol Oncol; 2013 May; 35(4):e174-7. PubMed ID: 23459375
[TBL] [Abstract][Full Text] [Related]
5. Rituximab-induced toxicity.
Mumoli N; Cei M
QJM; 2011 Mar; 104(3):265. PubMed ID: 20228132
[No Abstract] [Full Text] [Related]
6. [Recurrent infections in an ITP patient treated with rituximab].
Rosenberg-Bezalel S; Asher I; Sthoeger Z
Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
[TBL] [Abstract][Full Text] [Related]
7. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
[No Abstract] [Full Text] [Related]
8. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
Gall B; Yee A; Berry B; Bircham D; Hayashi A; Dansereau J; Hart J
J Obstet Gynaecol Can; 2010 Dec; 32(12):1167-1171. PubMed ID: 21176329
[TBL] [Abstract][Full Text] [Related]
9. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
[TBL] [Abstract][Full Text] [Related]
10. Rituximab induced psoriasis in an infant.
Fiorillo L; Wang C; Hemmati I
Pediatr Dermatol; 2014; 31(6):e149-51. PubMed ID: 25424224
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for patients with idiopathic thrombocytopenic purpura.
Peñalver FJ; Cabrera JR
Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
[No Abstract] [Full Text] [Related]
12. [Commentary on "Rituximab in thrombocytopenic purpura..."].
García-Álvarez JL
Rev Med Inst Mex Seguro Soc; 2012; 50(4):351-2. PubMed ID: 23234734
[No Abstract] [Full Text] [Related]
13. [Use of rituximab in resistant thrombocytopenic purpura].
Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
Rev Med Inst Mex Seguro Soc; 2012; 50(2):203-8. PubMed ID: 22882991
[TBL] [Abstract][Full Text] [Related]
14. [Reply to commentary on "Rituximab in thrombocytopenic purpura..."].
Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
Rev Med Inst Mex Seguro Soc; 2012; 50(4):353-4. PubMed ID: 23234735
[No Abstract] [Full Text] [Related]
15. Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Child N; O'Carroll M; Berkahn L
Intern Med J; 2012 Mar; 42(3):e12-4. PubMed ID: 22432995
[TBL] [Abstract][Full Text] [Related]
16. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
[TBL] [Abstract][Full Text] [Related]
17. B-cell depletion in immune thrombocytopenia.
Psaila B; Cooper N
Lancet; 2015 Apr; 385(9978):1599-601. PubMed ID: 25662418
[No Abstract] [Full Text] [Related]
18. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
[TBL] [Abstract][Full Text] [Related]
19. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia.
Arnold DM; Heddle NM; Carruthers J; Cook DJ; Crowther MA; Meyer RM; Liu Y; Cook RJ; McLeod A; MacEachern JA; Mangel J; Anderson D; Vickars L; Tinmouth A; Schuh AC; Kelton JG
Blood; 2012 Feb; 119(6):1356-62. PubMed ID: 22223819
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory autoimmune hepatitis with rituximab.
D'Agostino D; Costaguta A; Álvarez F
Pediatrics; 2013 Aug; 132(2):e526-30. PubMed ID: 23821693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
